These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36049818)

  • 1. Racial and Genetic Differences in Presentation of Transthyretin Amyloid Cardiomyopathy With Impaired Left Ventricular Function.
    Martyn T; Saef J; Dey AR; Khedraki R; Jain V; Collier P; Jaber WA; Estep JD; Hanna M; Tang WHW
    JACC Heart Fail; 2022 Sep; 10(9):689-691. PubMed ID: 36049818
    [No Abstract]   [Full Text] [Related]  

  • 2. Racial and Genetic Differences: Possible Health Disparities in Transthyretin Amyloid Cardiomyopathy Patients?
    Muller SA; van der Meer MG; Oerlemans MIFJ
    JACC Heart Fail; 2023 Jan; 11(1):130. PubMed ID: 36599542
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply: Racial and Genetic Differences: Possible Health Disparities in Transthyretin Amyloid Cardiomyopathy Patients?
    Martyn T; Saef J; Khedraki R; Hanna M; Tang WHW
    JACC Heart Fail; 2023 Jan; 11(1):130-131. PubMed ID: 36599541
    [No Abstract]   [Full Text] [Related]  

  • 4. Trajectory of left ventricular geometry and diastolic dysfunction in hereditary transthyretin cardiac amyloidosis.
    Akatsuka T; Fujimoto N; Ishiyama M; Nakamori S; Imanaka-Yoshida K; Dohi K
    ESC Heart Fail; 2021 Aug; 8(4):3422-3426. PubMed ID: 34145794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial Commentary: Advances in transthyretin amyloid cardiomyopathy.
    Benson MD; Dasgupta NR
    Trends Cardiovasc Med; 2021 Jan; 31(1):67-68. PubMed ID: 31948855
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutant Thr95Ile Transthyretin-Related Cardiac Amyloidosis With Polyneuropathy.
    Kim K; Oh J; Lee ST; Shim HS; Kang SM
    Circ J; 2019 Oct; 83(11):2328. PubMed ID: 31243187
    [No Abstract]   [Full Text] [Related]  

  • 7. Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg.
    Watanabe T; Obayashi K; Misumi Y; Tasaki M; Shinriki S; Ando T; Akagami T; Ueda M; Yamashita T; Hirotani S; Ando Y
    Amyloid; 2017 Mar; 24(sup1):119. PubMed ID: 28434332
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary Cardiac Involvement in the Rare Transthyretin Ile73Val Mutation: A Case Series.
    Kumar P; Paramasivam G; Devasia T; K P; A M; Nayak K; Joshi MB; Moka R
    Circ Genom Precis Med; 2020 Jun; 13(3):e002792. PubMed ID: 32393063
    [No Abstract]   [Full Text] [Related]  

  • 9. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation.
    Tini G; Vianello PF; Gemelli C; Grandis M; Canepa M
    J Cardiovasc Transl Res; 2019 Dec; 12(6):514-516. PubMed ID: 30604309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis.
    Petkow-Dimitrow P; Rajtar-Salwa R; Holcman K; Kostkiewicz M; Rubiś P
    Pol Arch Intern Med; 2020 Feb; 130(2):153-154. PubMed ID: 31933485
    [No Abstract]   [Full Text] [Related]  

  • 11. Bio-Profiling of Transthyretin Amyloid Cardiomyopathy.
    Mehmood M
    JACC Heart Fail; 2021 May; 9(5):403-404. PubMed ID: 33926733
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply: Bio-Profiling of Transthyretin Amyloid Cardiomyopathy.
    Rapezzi C; Sultan MB; Maurer MS
    JACC Heart Fail; 2021 May; 9(5):404. PubMed ID: 33926735
    [No Abstract]   [Full Text] [Related]  

  • 13. Transthyretin Glu54Leu - an unknown mutation within the Swedish population associated with amyloid cardiomyopathy and a unique fibril type.
    Hellman U; Lång K; Ihse E; Jonasson J; Olsson M; Lundgren HE; Pilebro B; Westermark P; Wixner J; Anan I
    Scand J Clin Lab Invest; 2019 Oct; 79(6):372-376. PubMed ID: 31169435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of transthyretin cardiomyopathy with a TTR-specific antisense oligonucleotide (IONIS-TTR
    Benson MD; Ackermann EJ; Monia BP
    Amyloid; 2017 Mar; 24(sup1):134-135. PubMed ID: 28434337
    [No Abstract]   [Full Text] [Related]  

  • 15. A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy.
    Huda A; Castaño A; Niyogi A; Schumacher J; Stewart M; Bruno M; Hu M; Ahmad FS; Deo RC; Shah SJ
    Nat Commun; 2021 May; 12(1):2725. PubMed ID: 33976166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic embolism in transthyretin amyloid cardiomyopathy: how to look into the future.
    Clemmensen TS; Poulsen SH
    Eur J Heart Fail; 2022 Aug; 24(8):1397-1399. PubMed ID: 35790492
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G > T, p.Ala140Ser).
    Patel K; Tagoe C; Bieri P; Weidenheim K; Tauras JM
    Amyloid; 2018 Sep; 25(3):211-212. PubMed ID: 30039724
    [No Abstract]   [Full Text] [Related]  

  • 18. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthyretin amyloid cardiomyopathy.
    Garcia-Pavia P; Domínguez F; Gonzalez-Lopez E
    Med Clin (Barc); 2021 Feb; 156(3):126-134. PubMed ID: 33138983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.